Literature DB >> 10624576

[Genetic factors and a polygenic model of Alzheimer's disease].

E I Rogaev1.   

Abstract

Genetic factors are responsible, to a certain degree, for many, if not all, Alzheimer's disease (AD) cases. A certain proportion of early-onset (below 65 years of age) AD cases follows an autosomal dominant mode of inheritance. Three genes were identified whose mutations account for 50-70% of early-onset monogenic AD cases in AD pedigrees. These are the genes of the amyloid precursor protein (APP) and two presenilins (PS I and PS II). The polymorphic variant of apolipoprotein E, APOE epsilon 4, is a genetic causative factor in familial and sporadic cases of various early- and late-onset AD forms (it is found, in general, in 20-50% of all AD cases). The action of the epsilon 4 allele is codominant, with the AD risk increased in homozygotes (epsilon 4/epsilon 4 > epsilon 4 > epsilon 3 or epsilon 2). In contrast to the mutations in the PS I and APP genes, the APOE epsilon 4 allele is not a necessary and sufficient condition for AD development. Mutations in these genes have not been found in a proportion of familial early-onset AD cases and are not causative factors in the majority of late-onset familial and sporadic forms. The genes determining AD are evolutionarily conservative and are expressed in all human tissues as early as at initial ontogenetic stages. This raises the question as to why AD is a progressive disorder affecting certain cerebral regions only at middle or old age. A hypothesis and model are suggested to explain the interaction between evolutionary, ontogenetic, and epigenetic factors of the development of the central nervous system and the products of genes whose mutations result in AD. Findings of different mutant genes indicate that AD is a set of genetic disorders (ADs) with a common pathological manifestation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10624576

Source DB:  PubMed          Journal:  Genetika        ISSN: 0016-6758


  4 in total

1.  Genetic evidence for the involvement of variants at APOE, BIN1, CR1, and PICALM loci in risk of late-onset Alzheimer's disease and evaluation for interactions with APOE genotypes.

Authors:  Jalal Gharesouran; Maryam Rezazadeh; Aziz Khorrami; Morteza Ghojazadeh; Mahnaz Talebi
Journal:  J Mol Neurosci       Date:  2014-07-15       Impact factor: 3.444

Review 2.  Amyloidosis in Alzheimer's Disease: Pathogeny, Etiology, and Related Therapeutic Directions.

Authors:  Chen Ma; Fenfang Hong; Shulong Yang
Journal:  Molecules       Date:  2022-02-11       Impact factor: 4.411

3.  Genetic association of apolipoprotein E genotype with EEG alpha rhythm slowing and functional brain network alterations during normal aging.

Authors:  Natalya V Ponomareva; Tatiana V Andreeva; Maria Protasova; Rodion N Konovalov; Marina V Krotenkova; Ekaterina P Kolesnikova; Daria D Malina; Elena V Kanavets; Andrey A Mitrofanov; Vitaly F Fokin; Sergey N Illarioshkin; Evgeny I Rogaev
Journal:  Front Neurosci       Date:  2022-08-01       Impact factor: 5.152

4.  Age-dependent effect of Alzheimer's risk variant of CLU on EEG alpha rhythm in non-demented adults.

Authors:  Natalya Ponomareva; Tatiana Andreeva; Maria Protasova; Lev Shagam; Daria Malina; Andrei Goltsov; Vitaly Fokin; Andrei Mitrofanov; Evgeny Rogaev
Journal:  Front Aging Neurosci       Date:  2013-12-13       Impact factor: 5.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.